SPDR® S&P® Pharmaceuticals ETF

Fund Name:
SPDR® S&P® Pharmaceuticals ETF
State Street
Total Net Assets:
Related Index:
s&p pharmaceuticals select industry index
ETF Category: 
Expense Ratio: 
Net Asset Value: 
Recent NAV Premium: 
NAV Symbol: 
Number of Holdings: 
Annualized Yield: 
Annualized Distribution: 
XPH Dividend History » 
Stock Weight Amount
Cassava Sciences 5.19% $13,192,593
Zoetis INC. Class A 5.15% $13,067,572
Catalent 5.05% $12,826,634
Eli Lilly And Company 5.01% $12,734,397
Elanco Animal Health 5.00% $12,695,100
List of all 49 stocks held by XPH »
Quotes delayed 20 minutes

Buy (3.32 out of 4)
100th percentile
(ranked higher than approx. 100% of all etfs covered)
Based on data provided by Zacks Investment Research via
ETF Assets
SPY   $380,547,124,030
GLD   $60,303,965,258
XLK   $44,477,194,690
XLF   $40,020,005,045
XLV   $32,010,070,313
List of all 143 others »
Shares Short 666,257
Chg. from Last Month -57,993
Shares Outstanding 4,900,000
% of Shares Short 13.60%
Days to Cover 10.8
Based on third party short interest data.

XPH | SPDR® S&P® Pharmaceuticals ETF | ETF Channel |

Copyright © 2010 - 2021, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.